Core Viewpoint - RuiZhi Pharmaceutical has appointed Gao Yingying as the new secretary of the board of directors following the resignation of Xu Jian due to work adjustments [1][5]. Group 1: Appointment Details - Gao Yingying's term as the board secretary will last until the end of the sixth board of directors [1]. - The appointment was approved by the board of directors after a nomination by Chairman Woo Sweelian [1]. Group 2: Background of Gao Yingying - Gao Yingying, born in 1994, has a bachelor's degree and is currently pursuing a master's degree in business administration at Shanghai Normal University [3]. - She has experience as a planner, host, and editor at various broadcasting stations from 2016 to 2022 [3][4]. - Prior to joining RuiZhi Pharmaceutical, she served as the promotion director at Zhongshan Anxin New Retail Co., Ltd. starting in November 2022 [4]. Group 3: Comparison with Previous Secretary - Xu Jian, the previous board secretary, was born in 1984 and held a master's degree in law from Sun Yat-sen University [4]. - Xu Jian had extensive experience in investment banking, having worked at Guohai Securities and Ping An Securities before joining RuiZhi Pharmaceutical in November 2021 [4][5]. Group 4: Company Performance - RuiZhi Pharmaceutical is a provider of integrated research and production services for biopharmaceuticals and chemical drugs [6]. - The company reported a total net loss exceeding 1.1 billion yuan over 2023 and 2024, with a revenue of 817 million yuan in the first three quarters of the current year, representing a year-on-year growth of 13.68% [6]. - The net profit attributable to shareholders for the same period was 7.09 million yuan, showing a significant increase of 111.5% year-on-year [6]. Group 5: Stock Performance - As of December 10, RuiZhi Pharmaceutical's stock price was 9.98 yuan per share, with a decline of 3.95% since the beginning of December [7]. - The company's latest market capitalization stands at 5 billion yuan [7].

Core Viewpoint - The appointment of Gao Yingying as the new secretary of the board for Ruizhi Pharmaceutical marks a significant leadership change within the company, highlighting a trend of cross-industry transitions in executive roles [2][6]. Group 1: Leadership Change - On December 1, Ruizhi Pharmaceutical announced the resignation of its previous board secretary, Xu Jian, due to work adjustments, and appointed Gao Yingying as the new board secretary [2]. - Gao Yingying, born in 1994, has a background in broadcasting and has held various roles in media before transitioning to the pharmaceutical industry [4][6]. - The company emphasized that Gao possesses the necessary experience and qualifications for the role, having completed training for board secretaries as required by regulations [6]. Group 2: Compensation - The annual pre-tax salary for the board secretary from 2022 to 2024 is reported to be 1.67 million yuan, 1.4443 million yuan, and 1.508 million yuan, averaging approximately 1.54 million yuan per year [7]. Group 3: Company Performance - Ruizhi Pharmaceutical has faced consecutive losses in 2023 and 2024, with a total net loss exceeding 1.1 billion yuan [9]. - In the first three quarters of the current year, the company achieved a revenue of 818 million yuan, representing a year-on-year growth of 13.68%, while the net profit attributable to shareholders was 7.09 million yuan, up 111.5% year-on-year [9]. Group 4: Market Position - As of December 10, the stock price of Ruizhi Pharmaceutical was reported at 9.98 yuan per share, with a decline of 3.95% since the beginning of December, and the company's latest market capitalization stands at 5 billion yuan [10].